These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Microbial community organization designates distinct pulmonary exacerbation types and predicts treatment outcome in cystic fibrosis. Widder S; Carmody L; Opron K; Kalikin L; Caverly L; LiPuma J Res Sq; 2024 Mar; ():. PubMed ID: 38562856 [TBL] [Abstract][Full Text] [Related]
12. Cystic fibrosis lung environment and Pseudomonas aeruginosa infection. Bhagirath AY; Li Y; Somayajula D; Dadashi M; Badr S; Duan K BMC Pulm Med; 2016 Dec; 16(1):174. PubMed ID: 27919253 [TBL] [Abstract][Full Text] [Related]
13. The cystic fibrosis microbiome in an ecological perspective and its impact in antibiotic therapy. Magalhães AP; Azevedo NF; Pereira MO; Lopes SP Appl Microbiol Biotechnol; 2016 Feb; 100(3):1163-1181. PubMed ID: 26637419 [TBL] [Abstract][Full Text] [Related]
14. The role of multispecies social interactions in shaping Pseudomonas aeruginosa pathogenicity in the cystic fibrosis lung. O'Brien S; Fothergill JL FEMS Microbiol Lett; 2017 Aug; 364(15):. PubMed ID: 28859314 [TBL] [Abstract][Full Text] [Related]
15. Microbial ecology and adaptation in cystic fibrosis airways. Yang L; Jelsbak L; Molin S Environ Microbiol; 2011 Jul; 13(7):1682-9. PubMed ID: 21429065 [TBL] [Abstract][Full Text] [Related]